The Philadelphia Phillies are quickly approaching a breaking point with their current roster, as the organization faces mounting pressure to capture a World Series title before its competitive window narrows. After failing to advance past the NLDS in consecutive seasons, the front office is expected to reevaluate core pieces and make meaningful adjustments this offseason.
Even with potential changes ahead, the franchise remains committed to its centerpiece: Bryce Harper. Now fully transitioned into a full-time first baseman, Harper continues to anchor the lineup and embody the identity of the team. The 33-year-old produced another impressive campaign in 2025, finishing with a .261 batting average, a .357 on-base percentage, an .844 OPS, 27 home runs and 75 RBIs in 132 appearances.

Harper has now completed seven seasons in Philadelphia, still in pursuit of the championship that would solidify his legacy in one of baseball’s most demanding markets. Although the offseason typically offers players a chance to step away from the grind, Harper has remained committed to maintaining peak physical shape as he prepares for 2026. On Friday, he revealed on social media that he had undergone a medical procedure, posting a photo along with an explanation and gratitude toward his doctor.
“EBOO is a procedure in which 1/3 of your blood is drawn from your body, passed through a filtration and ozonation device, and then returned to your bloodstream,” he shared on Instagram. He also listed the perceived benefits, writing, “This will: Improve circulation, Reduce inflammation, Fight infections, Support immune function, Remove toxins, Increase energy.”

Harper’s place in MLB history is already well established. After entering the league as the No. 1 overall pick in 2010, he debuted with the Washington Nationals in 2012 and immediately fulfilled sky-high expectations by capturing Rookie of the Year. Across 14 seasons, Harper has accumulated an elite résumé that includes two MVPs, eight All-Star nods and four Silver Slugger awards. His landmark 13-year, $330 million deal with the Phillies in 2019 reshaped the franchise and firmly positioned him as its foundation.
However, the offseason has brought its share of tension. Team president Dave Dombrowski publicly questioned whether Harper could still perform at an MVP level, comments that Harper admitted were hurtful before the two eventually resolved their issues. The exchange fueled ongoing conversation about Harper’s long-term outlook as he moves deeper into his contract.
In the end, Harper’s ability to recapture his peak form could determine whether Philadelphia extends its championship aspirations—or watches its window start to close.